Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 2,740 | $177.06 | $485,151.80 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 7 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,980 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.05 to $177.13, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 776 | $174.94 | $135,753.44 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 6 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,720 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:30 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 31,875 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008350 · doc4.xml · derivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,875 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:30 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008350 · doc4.xml · derivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:30 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Tax withholdingCommon Stock | 37,721 | $179.30 | $6,763,375.30 |
DisclosureSEC source: 0001209191-21-008350 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,074.7241 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:30 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
Exercise / conversionCommon Stock | 69,375 | $47.97 | $3,327,918.75 |
DisclosureSEC source: 0001209191-21-008350 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,795.7241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 10,525 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,525 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 5,025 | $179.30 | $900,982.50 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 10,525 | $47.97 | $504,884.25 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 227 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008348 · doc4.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust (Spouse, Trustee) Disclosed balance after: 1,991 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GiftCommon Stock | 227 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008348 · doc4.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054.2729 F1 · balance_after: Includes an additional 40.0494 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 9,150 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · derivative · entry 7 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,150 Underlying: Common Stock · 9,150 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 6,878 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · derivative · entry 6 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,878 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 10,507 | $179.30 | $1,883,905.10 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,038 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 9,150 | $101.16 | $925,614.00 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Hall Charles JGroup President
|
Exercise / conversionCommon Stock | 6,878 | $81.96 | $563,720.88 |
DisclosureSEC source: 0001209191-21-008344 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 12,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · derivative · entry 11 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 12,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 5,829 | $179.30 | $1,045,139.70 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 8 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,171 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:26 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 12,000 | $47.97 | $575,640.00 |
DisclosureSEC source: 0001209191-21-008343 · doc4.xml · nonDerivative · entry 7 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:33 UTC |
Riley Wayne JosephDirector
|
SaleCommon Stock | 1,650 | $166.19 | $274,213.50 |
DisclosureSEC source: 0001209191-21-008359 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,119 F1 · kind: The sales of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:33 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantStock Appreciation Right · Derivative | 8,370 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008358 · doc4.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 8,370 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008356 · doc4.xml · derivative · entry 5 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
GrantStock Appreciation Right · Derivative | 18,830 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 12 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,830 Underlying: Common Stock · 18,830 shares Expires 2031-02-03 F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 29,750 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 11 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,750 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 35,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 10 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 42,750 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 9 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,750 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 45,000 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 8 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 62,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 7 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionStock Appreciation Right · Derivative | 62,500 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · derivative · entry 6 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Tax withholdingCommon Stock | 140,711 | $173.12 | $24,359,888.32 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · nonDerivative · entry 4 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,035 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionCommon Stock | 64,750 | $47.97 | $3,106,057.50 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · nonDerivative · entry 3 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionCommon Stock | 87,750 | $37.18 | $3,262,545.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · nonDerivative · entry 2 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,996 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:32 UTC |
WATERMAN ROBERT ASVP & General Counsel
|
Exercise / conversionCommon Stock | 125,000 | $22.95 | $2,868,750.00 |
DisclosureSEC source: 0001209191-21-008355 · doc4.xml · nonDerivative · entry 1 WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantStock Appreciation Right · Derivative | 8,370 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · derivative · entry 13 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 8,370 shares Expires 2031-02-03 F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 7,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · derivative · entry 12 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,340 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 5,125 | $0.00 Strike: $77.13 | $0.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · derivative · entry 11 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,125 shares Expires 2026-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on July 29, 2017. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 1,293 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · derivative · entry 10 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,293 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 1,550 | $170.94 | $264,957.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 5 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,496 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.94 to $171.94, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 8,375 | $173.12 | $1,449,880.00 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,046 Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 7,340 | $81.96 | $601,586.40 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 5,125 | $77.13 | $395,291.25 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 1,293 | $69.58 | $89,966.94 |
DisclosureSEC source: 0001209191-21-008354 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:31 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantStock Appreciation Right · Derivative | 10,460 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008353 · doc4.xml · derivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,460 Underlying: Common Stock · 10,460 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:30 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantStock Appreciation Right · Derivative | 36,610 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008352 · doc4.xml · derivative · entry 5 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,610 Underlying: Common Stock · 36,610 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:30 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantStock Appreciation Right · Derivative | 8,370 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008351 · doc4.xml · derivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Underlying: Common Stock · 8,370 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:30 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GrantStock Appreciation Right · Derivative | 18,830 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008350 · doc4.xml · derivative · entry 7 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,830 Underlying: Common Stock · 18,830 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:29 UTC |
Paslick P. MartinSVP and CIO
|
GrantStock Appreciation Right · Derivative | 15,690 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:29 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008348 · doc4.xml · derivative · entry 5 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:28 UTC |
Morgan Sandra L.SVP-Provider Relations
|
GrantStock Appreciation Right · Derivative | 6,280 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008347 · doc4.xml · derivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Underlying: Common Stock · 6,280 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:27 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantStock Appreciation Right · Derivative | 18,830 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008346 · doc4.xml · derivative · entry 10 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,830 Underlying: Common Stock · 18,830 shares Expires 2031-02-03 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.